• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Jennifer Sheets, CEO of Interim HealthCare, Talks Future in Home Care, its Potential to Partner with Hospitals and More

Podcast

In this week’s episode of Tuning Into the C-Suite, Briana Contreras of MHE chatted with CEO of Interim HealthCare, Jennifer Sheets. She and Jennifer discussed how COVID-19 has impacted the demand for home care, how hospitals can partner with the operation and how new pursuits in healthcare will affect home care in the future.

To listen to more episodes featured on Tuning Into The C-Suite, visit us on Spotify, Apple Podcasts and iHeartRadio.

Jennifer Sheets, CEO, Interim HealthCare

Jennifer Sheets, CEO, Interim HealthCare

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.